Mannkind (MNKD) Goodwill & Intangibles (2022 - 2026)
Mannkind (MNKD) reported Goodwill & Intangibles of $72.6 million for Q1 2026, up 915.93% year-over-year from $7.1 million in Q1 2025, and little changed quarter-over-quarter from $72.7 million in Q4 2025.
Mannkind (MNKD) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
Mannkind (MNKD) has 5 years of Goodwill & Intangibles data on file, last reported at $72.6 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $72.6 million, up 915.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.6 million (up 915.93% YoY), and the FY2025 annual result was $72.7 million, up 909.82% from the prior year.
- Goodwill & Intangibles steadied at $72.6 million in Q1 2026 per MNKD's latest filing, from $72.7 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $72.7 million in Q4 2025 and troughed at $3.0 million in Q2 2024.
- A 5-year average of $13.2 million and a median of $4.3 million in 2022 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2023 and 2026: Goodwill & Intangibles dropped 29.21% in 2023, then soared 915.93% in 2026.
- A 5-year view of Goodwill & Intangibles shows it stood at $3.1 million in 2022, then slipped by 1.6% to $3.0 million in 2023, then soared by 139.55% to $7.2 million in 2024, then surged by 909.82% to $72.7 million in 2025, then declined by 0.07% to $72.6 million in 2026.
- Business Quant data shows MNKD's Goodwill & Intangibles at $72.6 million in Q1 2026, $72.7 million in Q4 2025, and $7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.62 Mn |
| Dec 31, 2025 | 72.67 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 7.21 Mn |
| Jun 30, 2024 | 2.96 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 4.30 Mn |